Emmanuel Babagbotemi Omole

Dr. Emmanuel Babagbotemi Omole

Roswell Park Cancer Institute, Buffalo, Minnesota, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
EOEmmanuel Babagbotemi Omole
Emmanuel Babagbotemi Omole
ONOlachi Sandra Ndukwe
Olachi Sandra Ndukwe
Malaria remains a persistent global health challenge, particularly in sub-Saharan Africa, with Nigeria shouldering a disproportionate burden. Despite extensive interventions, insecticide-treated nets (ITNs) have emerged as a cost-effective tool in the World Health Organization’s malaria control strategy. Utilizing data from the 2021 Nigeria Malaria Indicator Survey, this study explores socio-demographic determinants influencing ITN utilization among specific cohorts—children under-5 years and pregnant women. Findings indicate that 56% of Nigerian households possessed at least one ITN, with significant utilization observed among rural households, households from the North West and North East geopolitical zones, and households in the second and lowest wealth quintiles ( p <0.05). Only 41.2% of children under-5 years old slept under an ITN on the night before the survey, underscoring notable coverage gaps. Statistical analyses reveal significant associations ( p < 0.05) between ITN usage and variables such as age, residence, geopolitical zone, and wealth quintile at both bivariate and multivariate analytical levels. ITN usage decreases with increasing child age and household wealth quintile. For pregnant women, almost half (50%) in all households slept under an ITN the night before the survey. At both bivariate and multivariate analytical levels, significant associations ( p < 0.05) were observed between ITN usage among pregnant women and variables such as geopolitical zone and household wealth quintile. Additionally, at the multivariate level, ITN utilization decreases with increasing educational level. Our study reveals the dynamic nature of ITN usage patterns, necessitating ongoing monitoring and adaptive strategies to address regional and socioeconomic differentials, while sustaining awareness initiatives to meet the targets set by the Nigeria National Malaria Strategic Plan.

28 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
EOEmmanuel Babagbotemi Omole
Emmanuel Babagbotemi Omole
IAIqbal Aijaz
Iqbal Aijaz
JJJames Ellegate Jr
James Ellegate Jr
EIEmily Isenhart
Emily Isenhart
Mohamed Mokhtar DesoukiMohamed Mokhtar Desouki
Mohamed Mokhtar Desouki
KEKevin H. Eng
Kevin H. Eng
Like BRCA2, MAGEC3 is an ovarian cancer predisposition gene that has been shown to have prognostic significance in ovarian cancer patients. Despite the clinical significance of each gene, no studies have been conducted to assess the clinical significance of their combined expression. We therefore sought to determine the relationship between MAGEC3 and BRCA2 expression in ovarian cancer and their association with patient characteristics and outcomes. Immunohistochemical staining was quantitated on tumor microarrays of human tumor samples obtained from 357 patients with epithelial ovarian cancer to ascertain BRCA2 expression levels. In conjunction with our previously published MAGEC3 expression data, we observed a weak inverse correlation of MAGEC3 with BRCA2 expression (r = −0.15; p < 0.05) in cases with full-length BRCA2. Patients with optimal cytoreduction, loss of MAGEC3, and detectable BRCA2 expression had better overall (median OS: 127.9 vs. 65.3 months, p = 0.035) and progression-free (median PFS: 85.3 vs. 18.8 months, p = 0.002) survival compared to patients that were BRCA2 expressors with MAGEC3 normal levels. Our results suggest that combined expression of MAGEC3 and BRCA2 serves as a better predictor of prognosis than each marker alone.